Succimer vial is used to assess kidney function and structure
Ended Awarded Last action
- Contract number
- HT001425F0015
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $58,392
Award facts
- Contract value 100% obligated
- $58,392.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20810, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $58,392 |
About this award
Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. specializing in radiopharmaceuticals and medical isotopes, was awarded a Blanket Purchase Agreement (BPA) call valued at $58,392.00 by the Defense Health Agency on December 19, 2024. The award is structured as a firm fixed-price contract with no set-aside designation and will be performed in Bethesda, Maryland, with an ultimate completion date of December 11, 2025. The contract pertains to Succimer vial, a diagnostic imaging product used to assess kidney function and structure. As a critical supplier of nuclear medicine and diagnostic imaging products to federal healthcare agencies, Cardinal Health 414 maintains an extensive portfolio of radiopharmaceutical offerings and holds substantial Indefinite Delivery Vehicle contracts and BPAs with the Defense Health Agency valued at $7.5 million and $3.45 million to $5.54 million, enabling flexible procurement of time-sensitive radiopharmaceutical supplies across military treatment facilities.
This award represents a delivery order call under Cardinal Health 414's broader BPA framework with the Defense Health Agency, reflecting the company's established role as a specialized supplier of diagnostic and therapeutic nuclear medicine products to the Department of Defense's healthcare system. The company's federal contracting history demonstrates consistent capability in meeting stringent regulatory requirements, including Nuclear Regulatory Commission licensing and FDA approval for radiopharmaceuticals, as well as compliance with Department of Transportation regulations for radioactive materials transport. Cardinal Health 414's performance record across numerous similar contracts with the Veterans Health Administration and Defense Health Agency establishes its operational competency for delivering time-sensitive radiopharmaceutical products with demanding delivery requirements.
Quick answers
Who was awarded contract HT001425F0015?
HT001425F0015 was awarded to Cardinal Health 414, LLC by Defense Health Agency (Department of Defense) on December 19, 2024.
How much is contract HT001425F0015 worth?
The government has obligated $58,392 on HT001425F0015.
Is contract HT001425F0015 an order under another contract?
Yes. HT001425F0015 is a BPA call under HT001420A0031, a blanket purchase agreement.
Was contract HT001425F0015 competed?
The extent of competition for HT001425F0015 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award